Pharmaceutical

Dermavant acquisition expands Organon’s dermatology portfolio

Organon has completed the acquisition of Dermavant Sciences, a subsidiary of Roivant, to expand its dermatology portfolio.

Oct 30, 2024 - 04:00
Dermavant acquisition expands Organon’s dermatology portfolio
Organon has completed the acquisition of Dermavant Sciences, a subsidiary of Roivant, to expand its dermatology portfolio.
Read the original article

Tags:

Previous Article

Arrivo targets major depressive disorder in females after early efficacy data

Next Article

Bavarian eyes Mpox vaccine label expansion to include toddlers, kickstarts Phase...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Liquid Filling Innovations: Transforming Beverage and Pharmaceutical Industries with Capmatic

Liquid Filling Innovations: Transforming Beverage and P...

Oct 2, 2023

Vicebio secures $100m to advance RSV and hMPV vaccine combo to Phase I

Vicebio secures $100m to advance RSV and hMPV vaccine c...

Sep 24, 2024

A needle-free anaphylaxis treatment runs into an FDA roadblock

A needle-free anaphylaxis treatment runs into an FDA ro...

Sep 20, 2023